Scott Canute
Founder chez Magis Consulting LLC
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Lawrence Kenyon | M | 58 | 9 ans | |
Randy Thurman | M | 74 | 6 ans | |
Andrew Dickinson | M | 54 | 4 ans | |
Kurt Hilzinger | M | 63 |
University of Michigan
| 14 ans |
Christina Carlson | F | - | 4 ans | |
Faisal Ghiath Munir Sukhtian | M | 39 | 7 ans | |
Carolyn Beaty Scimemi | F | - | 8 ans | |
Cynthia Smith | F | 55 | 6 ans | |
Brett Pletcher | M | 56 | 4 ans | |
Yazan Haddadin | M | 48 | 7 ans | |
Steven Gilman | M | 71 | 6 ans | |
Adrian Adams | M | 73 | 6 ans | |
Michael Rogers | M | 64 | 6 ans | |
Jon Fyrwald | M | 63 | 19 ans | |
Scott A. Young | M | - | 8 ans | |
Robert Bartlett | M | - |
University of Michigan
| 44 ans |
Dennis G. Severance | M | 80 |
University of Michigan
| 46 ans |
Edgardo Hernandez | M | - | 19 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Clayman | M | 72 | 14 ans | |
David M. Goldenberg | M | 85 | 36 ans | |
Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 ans |
Karen L. Tubridy | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 2 ans |
Harout Semerjian | M | 52 | - | |
Michael Pehl | M | 60 | 2 ans | |
Donald Griffith | M | 75 | 7 ans | |
Nicole Hadas | F | 51 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 12 ans |
George H. Vincent | M | - |
University of Michigan
| 7 ans |
Usama Mohammad Fayyad | M | 60 |
University of Michigan
| 11 ans |
Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
John Butler | M | 59 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 ans |
Muneer Satter | M | 63 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 7 ans |
Mitch A. Mondry | M | - |
University of Michigan
| 8 ans |
Gregory D. Phelps | M | 75 | 8 ans | |
C. Merrifield | F | 73 | 7 ans | |
Sahijdak Walter | M | - |
University of Michigan
| 32 ans |
Michael R. Garone | M | 66 | 3 ans | |
Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 ans |
Larry Barr | M | - |
University of Michigan
| 6 ans |
Neil Bodick | M | 77 | 13 ans | |
Theresa McNeely | F | 60 | 2 ans | |
Joe Thomas | M | - | 2 ans | |
Jodie Morrison | F | 48 | 2 ans | |
Christina Willwerth | F | 53 | 12 ans | |
Lisa Davidson | F | 58 | 6 ans | |
William R. Gillespie | M | - |
University of Michigan
| 4 ans |
Michael A. Sosin | M | 64 |
University of Michigan
| 8 ans |
Usama Malik | M | 49 | 3 ans | |
Katherine A. Lauer | F | - |
University of Michigan
| 7 ans |
David Arkowitz | M | 62 | 3 ans | |
Daniel Hamburger | M | 60 |
University of Michigan
| 5 ans |
Beverly J. Seay | F | - |
University of Michigan
| 6 ans |
Robin Hoke | F | - | 2 ans | |
Mark de Rosch | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 6 ans |
Charles Baum | M | 65 | 1 ans | |
Dmitry Kobyzev | M | 38 | 2 ans | |
Kevyn Duane Orr | M | 66 |
University of Michigan
| 8 ans |
Michael Wyzga | M | 69 | 4 ans | |
Albert Dyrness | M | 61 | 2 ans | |
Jöerg Windisch | M | 53 | 1 ans | |
John Yee | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 ans |
Pedro Granadillo | M | 77 | 34 ans | |
Robert Barnett | M | - |
University of Michigan
| 7 ans |
Paul F. DePond | M | 69 |
University of Michigan
| 5 ans |
Jared M. Freedberg | M | 55 | 2 ans | |
KULDEEP NEOTE | M | - | 17 ans | |
Mallory Morales | F | 40 | 2 ans | |
Webster Dunbar | M | 62 | 5 ans | |
Izzet Garih | M | 63 |
University of Michigan
| 5 ans |
Duane Nash | M | 53 | 5 ans | |
Heath Lukatch | M | 57 | 9 ans | |
Jonathan Leff | M | 55 | 2 ans | |
Samuel D. Colella | M | 84 | 13 ans | |
Tony Kingsley | M | 60 | 4 ans | |
Arthur Chadwick | M | 67 |
University of Michigan
| 6 ans |
Anmar Karim Sarafa | M | - |
University of Michigan
| 4 ans |
Scott D. Kelley | M | 65 | 5 ans | |
Barbara Duncan | F | 59 | 1 ans | |
Ronald Renaud | M | 55 | 4 ans | |
Patrick Mahaffy | M | 61 | 12 ans | |
Anupam Dalal | M | 52 | 8 ans | |
Alan Milinazzo | M | 64 | 10 ans | |
Todd Brady | M | 52 | 3 ans | |
Jeffrey Henderson | M | 59 | 7 ans | |
Roy Liu | M | 63 |
University of Michigan
| 10 ans |
Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 ans |
Timothy Haines | M | 67 | 5 ans | |
Andrew Schwab | M | 53 | 6 ans | |
Michael Heffernan | M | 59 | 4 ans | |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Prokopios Tsirigakis | M | 69 |
University of Michigan
| 5 ans |
John Sloss | M | - |
University of Michigan
| 7 ans |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Jim DePorre | M | - |
University of Michigan
| 8 ans |
Rolf K. Hoffmann | M | 64 | 17 ans | |
Per A. Ramfjord | M | - |
University of Michigan
| 8 ans |
Mark Enyedy | M | 60 | 3 ans | |
Hung Shih | M | 68 |
University of Michigan
| 5 ans |
Guru Kothandaraman | M | - |
University of Michigan
| 5 ans |
Gil Syswerda | M | - |
University of Michigan
| 5 ans |
Michael J. Barton | M | - |
University of Michigan
| 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Scott Canute
- Réseau Personnel